文献速递关节外科

无菌性松动翻修髋关节置换的全国病例量与经济负担:2012至2032年趋势与预测

National Case Volume and Economic Burden of Inpatient Revision Hip Arthroplasty for Aseptic Loosening: Trends and Future Projections From 2012 to 2032.
PubMed 文献 · J Arthroplasty · 2026-07-24

本研究基于全国代表性加权住院数据库,分析因无菌性松动行住院翻修髋关节置换的年度发病率和平均费用,并预测至2032年。结果显示大流行前年发病率从2012年11,070例降至2019年9,650例,大流行期最低5,894例(2021年);每次入院通胀调整后平均费用从2012年$28,810升至2022年$31,461,预测2032年达$36,424。

要点

  • 大流行前全国年发病率从2012年11,070例降至2019年9,650例,大流行期最低5,894例(2021年)。
  • 每次入院通胀调整后平均费用从2012年$28,810升至2022年$31,461,预测2032年$36,424。
  • 全国总费用从2012年$318,924,352降至2019年$296,561,705,大流行低点$198,713,285(2021年)。

核心结论

  • 自2012年以来,因无菌性松动行翻修髋关节置换的全国每次入院平均费用呈上升趋势。
  • 大流行期间住院翻修量下降,且至2022年(数据最后一年)仍保持低迷。
  • 预测显示全国总费用可能下降,但每次入院费用将持续上升,可能对政策制定者、保险方和骨科医生构成挑战。

研究设计与样本

  • 研究查询了全国代表性加权住院数据库,识别因无菌性松动行住院翻修髋关节置换的入院记录。
  • 计算了此类入院的全国年发病率和相关住院费用,并将平均费用结果预测至2032年。
  • 费用使用消费者价格指数数据调整为2022年美元以消除通胀影响。

主要发现

  • 大流行前全国年发病率逐渐下降,范围在2012年11,070例至2019年9,650例之间。
  • 大流行期间住院量下降至2021年低点5,894例。
  • 通胀调整后每次入院平均费用从2012年$28,810增至2022年$31,461。
  • 全国总费用从2012年$318,924,352降至2019年$296,561,705,大流行低点为2021年$198,713,285。
  • 预测至2032年通胀调整后每次入院费用将升至$36,424。

临床怎么用

  • 骨科医生应关注因无菌性松动行翻修髋关节置换的每次入院费用持续上升趋势。
  • 政策制定者和保险方需注意预测的每次入院费用上升可能带来的经济负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aseptic loosening after hip arthroplasty is a major complication often requiring revision procedures. Revision hip arthroplasty is associated with major morbidity and health care expenditure, but national volumes and associated economic burden of revision hip arthroplasty for aseptic loosening have not been characterized. In this study, we estimate the nationwide annual incidence and average costs of inpatient revision arthroplasty for prosthetic loosening and projected future costs. METHODS: A nationally representative weighted database of hospital admissions was queried to identify admissions for inpatient revision hip arthroplasty for aseptic loosening. The national annual incidence of such admissions and associated inpatient costs were calculated. The average cost results were then projected to the year 2032. Costs were adjusted for inflation to 2022 US dollars using Consumer Price Index data. RESULTS: In the prepandemic period, national annual incidence gradually declined, ranging between 11,070 in 2012 and 9,650 in 2019. Inpatient volumes fell in the pandemic period to a low of 5,894 in 2021. The inflation-adjusted average cost per admission increased from $28,810 in 2012 to $31,461 in 2022. National total costs fell from $318,924,352 in 2012 to $296,561,705 in 2019 and a pandemic low of $198,713,285 in 2021. Inflation-adjusted costs per admission were projected to rise to $36,424 by 2032. CONCLUSIONS: The national average cost per admission for revision hip arthroplasty for aseptic loosening has increased since 2012. Inpatient revision volume decreased in the pandemic period and remained depressed into 2022, the final year for which data is available. Projections suggest that while total nationwide costs may fall, costs per admission will continue to rise, potentially posing a challenge for policymakers, insurers, and orthopaedic surgeons in the coming years.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Pisharody VA, Nour G, Chowdary AR, et al. National Case Volume and Economic Burden of Inpatient Revision Hip Arthroplasty for Aseptic Loosening: Trends and Future Projections From 2012 to 2032. J Arthroplasty. 2026. PMID: 42498049. doi:10.1016/j.arth.2026.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。